Of note, because BCMA is expressed in myeloma cells and, more importantly, it is largely restricted to plasma cells and some mature B cells, the first CAR-T to be developed for MM targeted this surface protein [85]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.